BioSpace News Archive

Genetown

BrainsWay to Report Third Quarter 2021 Financial Results on November 17, 2021

BrainsWay Ltd. today announced that it will report its third quarter 2021 financial results as well as operational highlights before the open of the U.S. financial markets on Wednesday, November 17, 2021.

November 3, 2021
·
1 min read
Lexaria Announces Ambitious New Hypertension Study HYPER-H21-4

Lexaria Bioscience Corp. announces a significant new study to expand its hypertension clinical program and provides updates on three ongoing human clinical studies evaluating its proprietary DehydraTECH-CBD for potentially treating hypertension and heart disease.

November 3, 2021
·
9 min read
Pharm Country

Certara to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference

Certara, Inc. today announced that William F. Feehery, Chief Executive Officer, and Andrew Schemick, Chief Financial Officer will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference.

November 3, 2021
·
1 min read
Biotech Bay

Day One Announces Presentation at 2021 Connective Tissue Oncology Society (CTOS) Virtual Annual Meeting

Day One Biopharmaceuticals today announced an upcoming poster presentation at the 2021 Connective Tissue Oncology Society (CTOS) Virtual Annual Meeting, being held from November 10-13, 2021.

November 3, 2021
·
6 min read
Business

Cognition Therapeutics Adds Public Company Financial and Operational Expertise to Board of Directors with Appointment of Ellen B. Richstone

Cognition Therapeutics, Inc. today announced the addition of Ellen B. Richstone to the company’s board of directors

November 3, 2021
·
4 min read
Business

Ascendis Pharma A/S Announces Third Quarter 2021 Financial Results and Business Update Conference Call on November 10

Ascendis Pharma A/S (Nasdaq: ASND), today announced that the Company will hold a conference call and live webcast on Wednesday, November 10, 2021 at 4:30 p.m. Eastern Time (ET) to review its third quarter 2021 financial results and provide a business update.

November 3, 2021
·
4 min read
Business

Cara Therapeutics Announces CEO Transition

Cara Therapeutics, Inc. today announced that Christopher Posner, a current member of the Company’s Board of Directors, has been appointed President and Chief Executive Officer, effective November 9, 2021.

November 3, 2021
·
5 min read
FDA

Allena Pharmaceuticals Receives Fast Track Designation from FDA for the Development of ALLN-346 for Chronic Treatment of Hyperuricemia in Patients With Gout and Advanced Chronic Kidney Disease

Allena Pharmaceuticals, Inc. today announced that its orally-administered, urate-degrading enzyme, ALLN-346, has received Fast Track designation from the U.S. Food and Drug Administration (FDA).

November 3, 2021
·
7 min read
SOTIO to Present New Data from Phase 1 Study of IL-15 Superagonist, SOT101, at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

SOTIO will present three posters discussing data that highlight the encouraging safety and efficacy for SOT101 (SO-C101) as a monotherapy and in combination with pembrolizumab for the treatment of advanced solid tumors

November 3, 2021
·
2 min read
Business

Imcyse Appoints Gene Mack, MBA as Chief Financial Officer

Imcyse, a clinical-stage biopharmaceutical company pioneering the development of a new class of active and specific immunotherapies for the treatment of severe autoimmune diseases, announced the appointment of Gene Mack, MBA, as Chief Financial Officer.

November 3, 2021
·
3 min read